Rowan Announces $2.1M to Build Machine Learning-Powered Computational Tools for Chemistry

Startup aims to replace expensive, slow, quantum mechanics simulations with inexpensive, fast machine-learned potentials.

BOSTON, Dec. 9, 2024 — Rowan, a company building molecular design and simulation tools for scientists, today announced $2.1 million in pre-seed funding. Investors include Pillar VC, AI Grant, and angel investors.

"Modern algorithms and machine learning models can dramatically accelerate scientific R&D by replacing resource-intensive experiments," said Corin Wagen, PhD, CEO and founder of Rowan. "As Rowan helps more scientists use modern computational techniques, our company will accelerate the speed of scientific progress across drug discovery and materials science."

Rowan makes it possible for any scientist to run modern simulation workflows, not just experts in computational chemistry. Users can design, simulate, and analyze molecules and materials through the company's web platform. Rowan's capabilities include:

"Rowan is now my first port of call for QM modeling," said Lewis Martin, chief scientific officer of OpenBench. "The attention paid to pragmatic and benchmarked methods means the software suite is practical to incorporate into our workflows."

"Today, biotech and pharma companies can invest hundreds of millions of dollars developing a single drug, and conventional simulations struggle to accelerate this process," said Tony Kulesa, partner at Pillar VC. "Rowan is building the next generation of powerful computational tools to save these companies an extraordinary amount of time and money as they advance their research."

About Rowan
Rowan is building machine learning-powered computational tools to accelerate chemical innovation. To learn more, visit rowansci.com.

Banner background image

What to Read Next

Studying Scaling in Electron-Affinity Predictions

Studying Scaling in Electron-Affinity Predictions

Testing low-cost computational methods to see if they get the expected scaling effects right.
Sep 10, 2025 · Corin Wagen
Open-Source Projects We Wish Existed

Open-Source Projects We Wish Existed

The lacunæ we've identified in computational chemistry and suggestions for future work.
Sep 9, 2025 · Corin Wagen, Jonathon Vandezande, and Ari Wagen
How to Make a Great Open-Source Scientific Project

How to Make a Great Open-Source Scientific Project

Guidelines for building great open-source scientific-software projects.
Sep 9, 2025 · Jonathon Vandezande
ML Models for Aqueous Solubility, NNP-Predicted Redox Potentials, and More

ML Models for Aqueous Solubility, NNP-Predicted Redox Potentials, and More

the promise & peril of solubility prediction; our approach and models; pH-dependent solubility; testing NNPs for redox potentials; benchmarking opt. methods + NNPs; an FSM case study; intern farewell
Sep 5, 2025 · Eli Mann, Corin Wagen, and Ari Wagen
Machine-Learning Methods for pH-Dependent Aqueous-Solubility Prediction

Machine-Learning Methods for pH-Dependent Aqueous-Solubility Prediction

Prediction of aqueous solubility for unseen organic molecules remains an outstanding and important challenge in computational drug design.
Sep 5, 2025 · Elias L. Mann, Corin C. Wagen
What Isaiah and Sawyer Learned This Summer

What Isaiah and Sawyer Learned This Summer

Reflections from our other two interns on their time at Rowan and what they learned.
Sep 5, 2025 · Isaiah Sippel and Sawyer VanZanten
Benchmarking OMol25-Trained Models on Experimental Reduction-Potential and Electron-Affinity Data

Benchmarking OMol25-Trained Models on Experimental Reduction-Potential and Electron-Affinity Data

We evaluate the ability of neural network potentials (NNPs) trained on OMol25 to predict experimental reduction-potential and electron-affinity values for a variety of main-group and organometallic species.
Sep 4, 2025 · Sawyer VanZanten, Corin C. Wagen
Which Optimizer Should You Use With NNPs?

Which Optimizer Should You Use With NNPs?

The results of optimizing 25 drug-like molecules with each combination of four optimizers (Sella, geomeTRIC, and ASE's implementations of FIRE and L-BFGS) and four NNPs (OrbMol, OMol25's eSEN Conserving Small, AIMNet2, and Egret-1) & GFN2-xTB.
Sep 4, 2025 · Ari Wagen and Corin Wagen
Double-Ended TS Search and the Invisible Work of Computer-Assisted Drug Design

Double-Ended TS Search and the Invisible Work of Computer-Assisted Drug Design

finding transition states; the freezing-string method; using Rowan to find cool transition states; discussing drug design
Sep 3, 2025 · Jonathon Vandezande, Ari Wagen, Spencer Schneider, and Corin Wagen
The Invisible Work of Computer-Assisted Drug Design

The Invisible Work of Computer-Assisted Drug Design

Everything that happens before the actual designing of drugs, and how Rowan tries to help.
Aug 28, 2025 · Corin Wagen